MT4
gene geneOn this page
Also known as MTIV
Summary
MT4 (metallothionein 4, HGNC:18705) is a protein-coding gene on chromosome 16q13, encoding Metallothionein-4 (P47944). Seems to bind zinc and copper.
Predicted to enable metal ion binding activity. Predicted to be involved in several processes, including cellular response to zinc ion; detoxification of copper ion; and intracellular zinc ion homeostasis. Predicted to act upstream of or within intracellular monoatomic cation homeostasis. Predicted to be active in cytoplasm and nucleus.
Source: NCBI Gene 84560 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 14 total
- MANE Select transcript:
NM_032935
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18705 |
| Approved symbol | MT4 |
| Name | metallothionein 4 |
| Location | 16q13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MTIV |
| Ensembl gene | ENSG00000102891 |
| Ensembl biotype | protein_coding |
| OMIM | 606206 |
| Entrez | 84560 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000219162
RefSeq mRNA: 1 — MANE Select: NM_032935
NM_032935
CCDS: CCDS42165
Canonical transcript exons
ENST00000219162 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000684649 | 56568841 | 56568957 |
| ENSE00001303400 | 56565073 | 56565159 |
| ENSE00001327376 | 56567751 | 56567816 |
Expression profiles
Bgee: expression breadth ubiquitous, 108 present calls, max score 89.95.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0579 / max 77.8971, expressed in 7 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 154227 | 0.0579 | 7 |
Top tissues by expression
147 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 89.95 | gold quality |
| skin of leg | UBERON:0001511 | 88.20 | gold quality |
| zone of skin | UBERON:0000014 | 87.19 | gold quality |
| skin of abdomen | UBERON:0001416 | 86.96 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 75.43 | silver quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 72.99 | silver quality |
| trachea | UBERON:0003126 | 72.96 | silver quality |
| lower esophagus mucosa | UBERON:0035834 | 70.69 | gold quality |
| dorsal root ganglion | UBERON:0000044 | 69.75 | silver quality |
| metanephric glomerulus | UBERON:0004736 | 67.59 | gold quality |
| frontal pole | UBERON:0002795 | 65.81 | silver quality |
| thymus | UBERON:0002370 | 65.68 | silver quality |
| layer of synovial tissue | UBERON:0007616 | 65.56 | gold quality |
| endometrium epithelium | UBERON:0004811 | 65.28 | gold quality |
| esophagus mucosa | UBERON:0002469 | 62.44 | gold quality |
| middle frontal gyrus | UBERON:0002702 | 61.97 | silver quality |
| vagina | UBERON:0000996 | 60.62 | gold quality |
| Brodmann (1909) area 10 | UBERON:0013541 | 51.90 | gold quality |
| granulocyte | CL:0000094 | 50.58 | silver quality |
| ectocervix | UBERON:0012249 | 49.98 | gold quality |
| esophagus | UBERON:0001043 | 46.18 | gold quality |
| right lung | UBERON:0002167 | 41.44 | gold quality |
| uterine cervix | UBERON:0000002 | 39.83 | gold quality |
| right lobe of liver | UBERON:0001114 | 39.01 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 37.22 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| caudate nucleus | UBERON:0001873 | 37.01 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.69 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 2)
- The association of metallothionein-4 gene polymorphism and renal function in long-term lead-exposed workers (PMID:19921116)
- MT4 expression is significantly downregulated in human masticatory mucosa during wound healing (PMID:28005267)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | mt2 | ENSDARG00000041623 |
| mus_musculus | Mt4 | ENSMUSG00000031757 |
| rattus_norvegicus | Mt4 | ENSRNOG00000019004 |
Paralogs (11): MT3 (ENSG00000087250), MT1G (ENSG00000125144), MT2A (ENSG00000125148), MT1B (ENSG00000169688), MT1E (ENSG00000169715), MT1X (ENSG00000187193), MT1F (ENSG00000198417), MT1H (ENSG00000205358), MT1A (ENSG00000205362), MT1M (ENSG00000205364), MT1HL1 (ENSG00000244020)
Protein
Protein identifiers
Metallothionein-4 — P47944 (reviewed: P47944)
Alternative names: Metallothionein-IV
All UniProt accessions (1): P47944
UniProt curated annotations — full annotation on UniProt →
Function. Seems to bind zinc and copper. Could play a special role in regulating zinc metabolism during the differentiation of stratified epithelia.
Similarity. Belongs to the metallothionein superfamily. Type 1 family.
RefSeq proteins (1): NP_116324* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000006 | Metalthion_vert | Family |
| IPR017854 | Metalthion_dom_sf | Homologous_superfamily |
| IPR023587 | Metalthion_dom_sf_vert | Homologous_superfamily |
Pfam: PF00131
UniProt features (31 total): binding site 27, sequence variant 3, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P47944-F1 | 68.63 | 0.00 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (27): 6; 25; 27; 34; 35; 35; 37; 38; 38; 42; 45; 8 …
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-5661231 | Metallothioneins bind metals |
| R-HSA-5660526 | Response to metal ions |
| R-HSA-8953897 | Cellular responses to stimuli |
MSigDB gene sets: 106 (showing top):
MORF_RAGE, MORF_FLT1, GOBP_RESPONSE_TO_ZINC_ION, GOBP_CELLULAR_RESPONSE_TO_CADMIUM_ION, MORF_ATRX, GOBP_RESPONSE_TO_COPPER_ION, MORF_ESR1, EFC_Q6, GOBP_RESPONSE_TO_METAL_ION, MARTINEZ_RB1_TARGETS_DN, MORF_FANCG, GOBP_DETOXIFICATION, GOBP_CELLULAR_RESPONSE_TO_ZINC_ION, MORF_RAP1A, SANSOM_APC_TARGETS_UP
GO Biological Process (6): intracellular zinc ion homeostasis (GO:0006882), detoxification of copper ion (GO:0010273), cellular response to cadmium ion (GO:0071276), cellular response to copper ion (GO:0071280), cellular response to zinc ion (GO:0071294), intracellular monoatomic cation homeostasis (GO:0030003)
GO Molecular Function (1): metal ion binding (GO:0046872)
GO Cellular Component (2): nucleus (GO:0005634), cytoplasm (GO:0005737)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Response to metal ions | 1 |
| Cellular responses to stimuli | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular response to metal ion | 3 |
| intracellular monoatomic cation homeostasis | 1 |
| inorganic ion homeostasis | 1 |
| detoxification of inorganic compound | 1 |
| stress response to copper ion | 1 |
| response to cadmium ion | 1 |
| response to copper ion | 1 |
| response to zinc ion | 1 |
| intracellular monoatomic ion homeostasis | 1 |
| monoatomic cation homeostasis | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
322 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MT4 | H3BSS0 | H3BSS0 | 820 |
| MT4 | KRT4 | P19013 | 491 |
| MT4 | ATP7B | P35670 | 443 |
| MT4 | SLC30A1 | Q9Y6M5 | 440 |
| MT4 | KRT13 | P13646 | 424 |
| MT4 | KRT33A | O76009 | 414 |
| MT4 | MCIDAS | D6RGH6 | 406 |
| MT4 | MT3 | P25713 | 403 |
| MT4 | ATOX1 | O00244 | 377 |
| MT4 | MTF1 | Q14872 | 374 |
| MT4 | CCS | O14618 | 353 |
| MT4 | APRT | P07741 | 353 |
| MT4 | LOX | P28300 | 353 |
| MT4 | FBN1 | P35555 | 353 |
| MT4 | CP | P00450 | 352 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: O42152, O93593, P07216, P15786, P15787, P25127, P25128, P25713, P28184, P37359, P37360, P37361, P47944, P47945, P52720, P52723, P52724, P52725, P52727, P55944, P55945, P62678, P62679, P62680, P62681, P62682, P62711, P62712, P62713, P68494, P68495, P68497, P68498, P68501, P68502, P68503, P68504, P68505, Q05890, Q2MJS5
Diamond homologs: O18842, O19000, P02795, P02797, P02798, P02800, P02801, P02802, P02803, P02804, P04355, P04731, P04732, P04733, P07438, P09577, P09578, P0DM35, P11957, P13640, P14425, P17808, P18055, P47944, P47945, P49068, P55942, P55943, P58280, P67981, P67982, P67983, P68041, P68301, P68302, P68303, P68304, P79376, P79377, P79378
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
14 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 13 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
273 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:56565155:GTCTG:G | donor_gain | 1.0000 |
| 16:56565158:TGGTG:T | donor_loss | 1.0000 |
| 16:56565160:G:A | donor_loss | 1.0000 |
| 16:56565160:G:GG | donor_gain | 1.0000 |
| 16:56565161:T:A | donor_loss | 1.0000 |
| 16:56567817:G:GG | donor_gain | 1.0000 |
| 16:56565141:G:T | donor_gain | 0.9900 |
| 16:56565156:TCTG:T | donor_gain | 0.9900 |
| 16:56565157:CTG:C | donor_gain | 0.9900 |
| 16:56565158:TG:T | donor_gain | 0.9900 |
| 16:56565159:GG:G | donor_gain | 0.9900 |
| 16:56567815:GA:G | donor_gain | 0.9900 |
| 16:56565162:GAG:G | donor_loss | 0.9800 |
| 16:56567812:GAAGA:G | donor_gain | 0.9800 |
| 16:56565163:A:AG | donor_gain | 0.9700 |
| 16:56565164:G:GG | donor_gain | 0.9700 |
| 16:56567745:TTCTA:T | acceptor_loss | 0.9700 |
| 16:56567746:TCTA:T | acceptor_loss | 0.9700 |
| 16:56567747:CTA:C | acceptor_loss | 0.9700 |
| 16:56567748:TA:T | acceptor_loss | 0.9700 |
| 16:56567749:A:AC | acceptor_loss | 0.9700 |
| 16:56567750:G:A | acceptor_loss | 0.9700 |
| 16:56567814:AGA:A | donor_gain | 0.9700 |
| 16:56567815:GAG:G | donor_gain | 0.9700 |
| 16:56567721:C:G | acceptor_gain | 0.9400 |
| 16:56567749:A:AG | acceptor_gain | 0.9400 |
| 16:56567750:G:GG | acceptor_gain | 0.9400 |
| 16:56567748:TAGG:T | acceptor_gain | 0.9200 |
| 16:56567749:AGGA:A | acceptor_gain | 0.9200 |
| 16:56567750:GGAG:G | acceptor_gain | 0.9200 |
AlphaMissense
409 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000082211 (16:56567222 C>G), RS1000867433 (16:56566091 G>A), RS1001746466 (16:56568301 G>C,T), RS1003708720 (16:56564562 C>T), RS1004784786 (16:56567177 C>A,G,T), RS1005559681 (16:56567983 T>C), RS1006009511 (16:56568196 G>A), RS1007780631 (16:56563880 G>A), RS1008453143 (16:56566442 G>A,C), RS1010087014 (16:56567457 C>A,G), RS1010533967 (16:56567675 A>G,T), RS1010606868 (16:56564615 T>C), RS1011614248 (16:56563364 T>C), RS1011797975 (16:56568720 T>C,G), RS1012239798 (16:56565557 G>A,T)
Disease associations
OMIM: gene MIM:606206 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST009303_14 | Abstraction and mental flexibility | 4.000000e-06 |
| GCST010241_3 | Apolipoprotein A1 levels | 1.000000e-19 |
| GCST010242_284 | HDL cholesterol levels | 1.000000e-28 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009332 | executive function measurement |
| EFO:0004614 | apolipoprotein A 1 measurement |
| EFO:0004612 | high density lipoprotein cholesterol measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cyclosporine | increases expression | 2 |
| GSK-J4 | increases expression | 1 |
| pinosylvin | increases expression | 1 |
| Lead | affects response to substance | 1 |
| Mercury | affects abundance | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Silver Nitrate | increases expression | 1 |
| Thiram | increases expression | 1 |
| Zinc | increases expression | 1 |
| Ziram | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Antirheumatic Agents | decreases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.